News & Analysis on Clinical Trial Services & Contract Research And Development
People on the Move
By Melissa Fassbender
- Last updated on
Mary Mattes, who has held senior roles at Accelovance and PRA, has joined Synteract as senior vice president, biometrics and drug safety.
“I’m excited to lead the Biometrics and Drug Safety teams at Synteract, as the company is perfectly positioned to support innovative clients through our growing global team and data-centered offerings,” Mattes told us.
“Synergy can be built working across these technology and data driven teams that are at the core of clinical trial delivery,” she said.
“By harnessing this synergy, we will create an even more efficient and harmonious team that uses data to deliver insights to the sponsor and project teams to more effectively run clinical trials.”
Mattes was most recently executive vice president, global biometrics and information technology at Accelovance. She also worked at PRA for ten years.